As cell therapies such as Chimeric Antigen Receptor T-Cell (CAR T) Therapy and Bone Marrow Transplant (BMT) continue to transform treatment options, they also introduce unique challenges, one of the most significant being the need for a 24/7 family caregiver during and after treatment. While these therapies offer lifesaving potential, their success often depends not just on the clinical care but on the dedicated round-the-clock support provided by caregivers.

Objectives:

1. Understand how caregiver involvement directly impacts the success of CAR T and BMT, from pretreatment to post-discharge support
2. Highlight the multifaceted burdens caregivers experience, including navigating the complex healthcare system and providing round-the-clock care
3. Share actionable solutions to enhance the caregiver experience and improve patient outcomes

Register